Ono Pharmaceutical Co Ltd 2019 Sustainability Report
The report describes the company's FY2018 CSR activities, including a 2030 greenhouse-gas reduction target covering Scope 1, Scope 2 and Scope 3, progress on energy, water and waste management, and participation in the CDP, where it received an A climate score and B water score. It also documents the company's approval of science-based reduction targets, renewable-energy certificate purchases and broad social and employee initiatives. Selected sustainability information was subject to Deloitte Tohmatsu Sustainability's limited assurance engagement.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2019
Type: Sustainability Report
Pages: 85
Back to company
Ono Pharmaceutical Co Ltd
CSR Report
The report describes the company's FY2018 CSR activities, including a 2030 greenhouse-gas reduction target covering Scope 1, Scope 2 and Scope 3, progress on energy, water and waste management, and participation in the CDP, where it received an A climate score and B water score. It also documents the company's approval of science-based reduction targets, renewable-energy certificate purchases and broad social and employee initiatives. Selected sustainability information was subject to Deloitte Tohmatsu Sustainability's limited assurance engagement.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2018
Published
Sep 1, 2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Net Zero Target
Employees